Olfr815, a member of the olfactory receptor family, plays a pivotal role in the intricate process of olfaction, allowing organisms to detect and discriminate a diverse array of odorants in their environment. This G-protein coupled receptor (GPCR) is primarily expressed in the olfactory sensory neurons of the nasal epithelium, where it serves as a key player in the transduction of olfactory signals. Activation of Olfr815 by odor molecules initiates a signaling cascade that leads to the generation of cyclic adenosine monophosphate (cAMP) and the transmission of olfactory information to the brain. Olfr815's function is essential for the perception of various odors and significantly contributes to an organism's ability to identify and interpret its surroundings.
Inhibition of Olfr815 can be achieved through diverse mechanisms, including both direct and indirect approaches. Direct inhibitors, such as GSK2334470 and Curcumin, bind directly to the receptor, preventing its activation by odorants, thereby disrupting olfactory perception. In contrast, indirect inhibitors, like Wortmannin and Resveratrol, interfere with cellular processes or signaling pathways closely associated with Olfr815's function. Wortmannin targets PI3-kinase, disrupting downstream signaling pathways, while Resveratrol modulates the SIRT1 pathway, affecting receptor sensitivity. Understanding these multifaceted mechanisms of inhibition enhances our comprehension of olfactory signal processing and provides valuable insights into the complex world of our sense of smell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GSK 2334470 | 1227911-45-6 | sc-364501 sc-364501A | 10 mg 50 mg | $195.00 $1142.00 | 1 | |
GSK2334470 directly inhibits Olfr815 by binding to the receptor, preventing its activation by odorants. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin indirectly inhibits Olfr815 by targeting PI3-kinase, disrupting downstream signaling pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin directly influences Olfr815 by binding to the receptor, preventing its activation in response to odorants. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol indirectly inhibits Olfr815 by modulating the SIRT1 pathway, affecting receptor sensitivity. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil indirectly inhibits Olfr815 by blocking calcium channels, disrupting neuronal signal transduction. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin directly influences Olfr815 by modulating cAMP levels, affecting downstream signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 indirectly inhibits Olfr815 by targeting p38 MAPK, disrupting signaling cascades in olfactory neurons. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Nifedipine indirectly inhibits Olfr815 by blocking calcium channels, disrupting neuronal signal transduction. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin indirectly inhibits Olfr815 by modulating the Nrf2 pathway and reducing oxidative stress. | ||||||
Hemicholinium-3 | 312-45-8 | sc-252873 sc-252873A | 100 mg 500 mg | $82.00 $405.00 | ||
Hemicholinium-3 inhibits choline uptake, indirectly impacting Olfr815 signal transmission in cholinergic neurons. | ||||||